Biobanking Market by Product (Equipment, Consumables), Software, Services, Workflow (Collection, Storage, Transport), Operation, Sample type (Blood, Stem Cells, Nucleic Acid), Application, Ownership, Region, End User, Competition - Global Forecast to 2031

Market Size
$8.09B
MARKET SIZE, 2026
Projected Market Size
$12.38B
MARKET SIZE, 2031
CAGR
8.9%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

BIOBANKING MARKET SIZE, SHARE & GROWTH SNAPSHOT

biobanking-devices-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global biobanking market is projected to grow from USD 8.09 billion in 2026 to USD 12.38 billion by 2031, at a CAGR of 8.9% during the forecast period. The market was valued at USD 7.65 billion in 2025. It includes technologies, products, and services for collecting, processing, storing, preserving, managing, and distributing biological samples and related data. The market features biobanking equipment, consumables, storage solutions, sample and information management systems, and various services. It covers diverse biological materials such as blood, tissues, organs, fluids, stem cells, nucleic acids, and human waste. These solutions support pharmaceutical, biotech, academic, research, hospital, diagnostic, CRO, and biobank sectors, facilitating applications like drug discovery, biomarker and disease research, precision medicine, clinical studies, genomics, and regenerative medicine.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 7.65 Billion
    Current Market Size (2026): USD 8.09 Billion
    Forecast Market Size (2031): USD 12.38 Billion
    CAGR (2026–2031): 8.9%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America accounted for the largest market share of ~43.3% in 2025.
    Offering Leader: Products segment accounted for the largest market share of ~65.2% in 2025.
    Equipment Leader: Automated equipment is projected to be the fastest-growing segment, at a CAGR of 8.9% during the forecast period.
    Workflow Leader: Sample collection & storage accounted for the largest share in 2025.
    Biobank Leader: Biobanks dominated in 2025, with 53.3% of the market.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Thermo Fisher Scientific Inc, PHC Holdings Corporation, and BD & Co were identified as some of the star players in the global biobanking market, given their strong market share and product and service footprint.
    Askion, Cureline, and Baybiosciences have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The global biobanking market is expanding steadily, driven by the growing demand for high-quality biological samples, increasing investments in precision medicine and biopharmaceutical research, and rising adoption of advanced biobanking technologies across drug discovery, biomarker research, clinical research, genomics, and translational research.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Customer-side business trends in the biobanking market are driven by rising demand for high-quality biospecimens, precision medicine, and advanced biomedical research. Key trends include the growing use of diverse, well-characterized biospecimens; the expansion of population-based and disease-specific biobanks; the adoption of automated sample management and digital biobanking platforms; and increased outsourcing to biobanking service providers. Standardized sample collection, improved cryogenic storage, data integration, supply-chain traceability, and regulatory compliance are also shaping biobank development, procurement, sample management, and purchasing decisions.

biobanking-devices-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing adoption of precision medicine and biomarker-driven drug development
  • Growth of cell & gene therapy and other complex biologics manufacturing
RESTRAINTS
Impact
Level
  • High capital investment required for biobank infrastructure
  • Stringent regulatory and ethical requirements for human biospecimen handling
OPPORTUNITIES
Impact
Level
  • Growing focus on decentralized trials, remote collection and distributed patient access
  • Outsourcing of activities by SME biopharma companies to third party specialists
CHALLENGES
Impact
Level
  • Cybersecurity, interoperability and AI governance
  • Challenges associated with maintaining long-term sample quality and integrity

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing adoption of precision medicine and biomarker-driven drug development

Increasing adoption of precision medicine and biomarker-driven drug development is driving demand for well-characterized samples supporting discovery and validation.

Restraint: High capital investment required for biobank infrastructure

High capital investment required for biobank infrastructure limits adoption among smaller institutions due to costly storage systems, equipment, and maintenance.

Opportunity: Growing focus on decentralized trials, remote collection and distributed patient access

Growing focus on decentralized trials, remote collection, and distributed patient access creates demand for decentralized biobanking networks and sample logistics.

Challenge: Cybersecurity, interoperability and AI governance

Cybersecurity, interoperability, and AI governance pose challenges in protecting sensitive sample data, integrating systems, and ensuring transparent, compliant AI use.

BIOBANKING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
 Provides biobanking solutions including sample collection and preparation equipment, cryogenic tubes and containers, ultra-low-temperature freezers, automated sample handling, cold-chain logistics, and data management solutions for research and clinical biobanks Enables secure preservation and traceability of biological samples while supporting standardized collection, processing, storage, transport, and inventory management across biobanking workflows
company logo
 Provides automated and outsourced biobanking solutions covering biological sample storage, biorepository services, sample tracking, cold-chain logistics, automated retrieval, and Limfinity® biobanking LIMS for lifecycle management of research and clinical samples Improves sample integrity, traceability, retrieval efficiency, and inventory visibility while enabling compliant, scalable management of biological samples across multiple storage locations

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The global biobanking market functions as a highly interconnected ecosystem where pharmaceutical and biotech firms, academic and research institutions, hospitals, diagnostic labs, and biobanks work together to gather, process, preserve, store, and manage biological samples and related data. Technology providers supply advanced sample collection systems, automated storage and retrieval platforms, cryogenic devices, lab instruments, consumables, and biobanking information management tools. Contract research organizations (CROs), biorepository service providers, and specialized logistics firms support sample collection, processing, storage, inventory management, transportation, and distribution throughout research and clinical development processes. Regulatory agencies and healthcare systems in regions like North America and Europe set evolving standards for sample quality, traceability, data privacy, ethical use, and biospecimen management—fostering standardization, automation, compliance, and adoption of biobanking solutions in fields such as precision medicine, drug discovery, biomarker research, clinical research, genomics, and translational science.

biobanking-devices-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Global Biobanking Market, by Offering

In 2025, products accounted for the largest share, supported by widespread adoption of biobanking equipment, consumables, storage systems, sample collection products, and preservation solutions.

Global Biobanking Market, by Equipment

In 2025, manual equipment accounted for the largest share, driven by its widespread use in sample collection, processing, handling, and storage across biobanks and research laboratories.

Global Biobanking Market, by Workflow

In 2025, sample collection & storage accounted for the largest share, supported by the growing need for standardized collection, preservation, and long-term storage of biological specimens.

Global Biobanking Market, by Sample Type

In 2025, blood products accounted for the largest share, driven by their extensive use in disease research, biomarker discovery, diagnostics, and clinical research.

Global Biobanking Market, by Product End User

In 2025, biobanks accounted for the largest share, reflecting their extensive use of biobanking products for sample collection, processing, preservation, storage, and inventory management.

Global Biobanking Market, by Service Type

In 2025, physical biobanking services accounted for the largest share, driven by increasing outsourcing of sample collection, processing, storage, retrieval, and distribution activities.

Global Biobanking Market, by Ownership

In 2025, private & commercial biobanks accounted for the largest share, supported by increasing investments in biospecimen repositories and growing demand from pharmaceutical and biotechnology companies.

Global Biobanking Market, by Service End User

In 2025, pharmaceutical & biotechnology companies accounted for the largest share, driven by increasing demand for high-quality biospecimens supporting drug discovery, biomarker research, and clinical development.

Global Biobanking Market, by Application

In 2025, research applications accounted for the largest share, supported by increasing use of biological samples in disease research, drug discovery, biomarker identification, and translational research.

REGION

Asia Pacific to be fastest-growing region in market during forecast period

During the forecast period, Asia Pacific is expected to experience rapid growth in the biobanking market, driven by rising investments in precision medicine, genomics, and biomedical research, as well as the growing adoption of advanced technologies for sample collection, processing, preservation, and storage. The expansion of pharmaceutical and biotechnology research, biobanking infrastructure, CRO services, and clinical research activities further supports regional market growth.

biobanking-devices-market Region

BIOBANKING MARKET: COMPANY EVALUATION MATRIX

In the global biobanking market, Thermo Fisher Scientific is the leading player, supported by its broad portfolio of sample collection, storage, processing, monitoring, and laboratory solutions. Its strong presence across research and biopharmaceutical organizations, along with a focus on automation and sample integrity, reinforces its market leadership. Agilent Technologies is an emerging player, driven by its SLIMS biobanking software, which supports sample tracking, inventory management, workflow automation, and data management. Its growing focus on digital biobank management and integrated workflows positions it well to benefit from increasing biobank automation.

biobanking-devices-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 7.65 Billion
Market Size in 2026 (Value) USD 8.09 Billion
Market Forecast in 2031 (Value) USD12.38 Billion
Growth Rate CAGR of 8.9% from 2026 to 2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Offering:
    • Products (Equipment [Freezers & Refrigerators
    • Temperature & Humidity Control Systems
    • Cryogenic Storage Systems
    • Thawing Equipment
    • Alarm and Monitoring Systems
    • and Other Equipment & Accessories]
    • Consumables)
    • Services
    • and Software
  • By Equipment Operation Type: Manual Equipment and Automated Equipment
  • By Workflow:
    • Sample Collection & Storage
    • Sample Processing
    • Sample Analysis
    • and Transport & Logistics
  • By Sample Type:
    • Blood Products
    • Solid Tissues & Organs
    • Stem Cells & Cell Lines
    • Nucleic Acids
    • Biological Fluids
    • and Human Waste Products
  • By Product End User: Biobanks and CROs
  • By Service Ownership Type:
    • Private/Commercial Biobanks
    • Academic and Research Institute Biobanks
    • National/Regional Agencies
    • Hybrid/PPP Models
    • and Other Ownership Models
  • By Application:
    • Research Applications (Life Science Research and Clinical Research)
    • Therapeutic Applications
    • Diagnostic Applications
    • and Other Applications
  • By Service Type:
    • Physical Biobanking
    • Virtual Biobanking
    • and Other Services
  • By Service End User: Pharma-Biotech Companies & CROs and Hospitals & Diagnostic Laboratories
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa

WHAT IS IN IT FOR YOU: BIOBANKING MARKET REPORT CONTENT GUIDE

biobanking-devices-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Evaluate the competitive positioning of key players in the biobanking market Benchmarked leading companies across biobanking equipment, consumables, sample storage, automation, monitoring systems, informatics, and biobanking services based on technology capabilities, workflow coverage, product and service offerings, geographic reach, and end-user focus Identifies competitive gaps, technology differentiation opportunities, strategic partnerships, and market positioning strategies
Assess high-growth biobanking technologies and application opportunities Evaluated growth potential across automated biobanking, cryogenic storage, sample management and tracking, digital biobank platforms, biospecimen processing, and integrated biobanking workflows Supports investment prioritization, technology development, portfolio expansion, automation strategies, and service diversification

RECENT DEVELOPMENTS

  • June 2026 : Merck KGaA entered into a definitive agreement to acquire Bio-Techne Corporation for approximately USD 11.3 billion in cash. The strategic acquisition expands Merck’s life science tools portfolio by integrating Bio-Techne’s specialized recombinant proteins, spatial biology tools, and ProteinSimple automated protein analysis platforms used to characterize and preserve biological specimens. This acquisition directly bolsters Merck's biobanking and bioprocessing capabilities by enhancing end-to-end analytical solutions required for managing, characterizing, and utilizing banked biosamples across genomics, proteomics, and cell therapy applications
  • May 2026 : Thermo Fisher Scientific unveiled its next-generation Orbitrap mass spectrometry platforms—the Orbitrap Tribrid Apex and Orbitrap Excedion—alongside its expanded Olink proteomics platform at the ASMS 2026 conference. The high-sensitivity platforms are engineered to connect molecular discovery workflows with large-scale population health initiatives, including active deployment within major biobank programs such as the PRECISE initiative. The development directly advances biobanking infrastructure by providing automated, population-scale multiomics characterization and biomarker discovery directly from deeply curated biorepository specimens.
  • April 2026 : QIAGEN showcased and advanced the commercial deployment of its next-generation automated sample preparation portfolio at AACR 2026, featuring the QIAsprint Connect platform alongside Parse Biosciences Evercode FFPE single-cell extraction kits. The QIAsprint Connect system automates high-throughput nucleic acid purification for up to 192 samples per run with minimal hands-on time, while Evercode FFPE enables whole-transcriptome sequencing from archived, formalin-fixed biospecimens. This development directly strengthens biobanking operations by standardizing high-volume bio-specimen extraction, preserving sample integrity, and streamlining downstream genomic analysis from biorepository collections.
  • January 2026 : PHC Corporation launched ECO 703VXH in North America for biorepositories, biopharmaceutical companies, and academic institutions. The freezer combines dual independent refrigeration, natural refrigerants, to support secure long-term storage of vaccines, cell lines, and therapeutic samples.
  • March 2025 : Cryoport launched MVE Biological Solutions' (MVE) High-Efficiency 800 C, an addition to its next-generation High-Efficiency (HE) Series of cryogenic freezers. The HE 800 C combines ergonomic features and consistent performance in a compact size to meet the evolving needs of fertility clinics, biorepositories and clinical laboratories.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
48
2
EXECUTIVE SUMMARY
 
 
 
 
 
54
3
PREMIUM INSIGHTS
 
 
 
 
 
60
4
MARKET OVERVIEW
Precision medicine and AI integration drive transformative biobanking market growth amidst regulatory challenges.
 
 
 
 
 
63
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING ADOPTION OF PRECISION MEDICINE AND BIOMARKER-DRIVEN DRUG DEVELOPMENT
 
 
 
 
 
 
4.2.1.2
GROWTH OF CELL & GENE THERAPY AND OTHER COMPLEX BIOLOGICS MANUFACTURING
 
 
 
 
 
 
4.2.1.3
INCREASING OUTSOURCING OF R&D, LABORATORY, AND SAMPLE-MANAGEMENT ACTIVITIES.
 
 
 
 
 
 
4.2.1.4
INCREASING INTEGRATION OF AI, DIGITAL TECHNOLOGIES, AND AUTOMATION IN BIOBANK MANAGEMENT
 
 
 
 
 
 
4.2.1.5
ADOPTION OF ENERGY-EFFICIENT ULT FREEZERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH CAPITAL INVESTMENT REQUIRED FOR BIOBANK INFRASTRUCTURE
 
 
 
 
 
 
4.2.2.2
STRINGENT REGULATORY AND ETHICAL REQUIREMENTS FOR HUMAN BIOSPECIMEN HANDLING
 
 
 
 
 
4.2.3
OPPORTUNITY
 
 
 
 
 
 
 
4.2.3.1
GROWING FOCUS ON DECENTRALIZED TRIALS, REMOTE COLLECTION, AND DISTRIBUTED PATIENT ACCESS
 
 
 
 
 
 
4.2.3.2
OUTSOURCING OF ACTIVITIES BY SME BIOPHARMA COMPANIES TO THIRD-PARTY SPECIALISTS
 
 
 
 
 
 
4.2.3.3
INCREASING FOCUS ON SUSTAINABILITY AND GREEN-LAB SOLUTIONS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
CYBERSECURITY, INTEROPERABILITY, AND AI GOVERNANCE
 
 
 
 
 
4.2.5
CHALLENGES
 
 
 
 
 
 
 
 
CHALLENGES ASSOCIATED WITH MAINTAINING LONG-TERM
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive pressures and seize investment opportunities in the evolving global biobanking landscape.
 
 
 
 
 
72
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL BIOBANKING MARKET
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE OF BIOBANKING SOLUTIONS, BY PRODUCT (2025)
 
 
 
 
 
 
 
AVERAGE SELLING PRICE TREND OF BIOBANKING SOLUTIONS,
 
 
 
 
 
 
 
AVERAGE SELLING PRICE TREND OF BIOBANKING EQUIPMENT,
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT & EXPORT DATA
 
 
 
 
 
 
5.6.2
IMPORT & EXPORT VOLUME
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING ACTIVITY
 
 
 
 
 
 
 
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFFS ON BIOBANKING MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.11.4.1
NORTH AMERICA
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.11.5.2
HOSPITALS & DIAGNOSTIC LABORATORIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven advancements revolutionize biobanking with automation, genomics, and robust patent innovations.
 
 
 
 
 
93
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
AI-DRIVEN BIOBANK MANAGEMENT
 
 
 
 
 
 
6.1.1.2
AUTOMATED & ROBOTIC BIOBANKING
 
 
 
 
 
6.1.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
GENOMICS & MOLECULAR ANALYSIS TECHNOLOGIES
 
 
 
 
 
 
6.1.2.2
IOT & REMOTE MONITORING
 
 
 
 
 
6.1.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
COLD-CHAIN & TEMPERATURE-CONTROLLED LOGISTICS
 
 
 
 
 
 
6.1.3.2
BIOINFORMATICS & CLOUD COMPUTING
 
 
 
 
6.2
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
 
TOP APPLICANTS/OWNERS (COMPANIES) FOR
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
6.5
IMPACT OF AI/GEN AI ON BIOBANKING MARKET
 
 
 
 
 
 
 
 
6.5.1
TOP USE CASES & MARKET POTENTIAL
 
 
 
 
 
 
6.5.2
CASE STUDIES OF AI IMPLEMENTATION IN BIOBANKING MARKET
 
 
 
 
 
 
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN BIOBANKING MARKET
 
 
 
 
7
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate evolving regulations to enhance sustainability initiatives and achieve industry-leading eco-certifications.
 
 
 
 
 
103
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock the strategic influence of stakeholders in biobanking purchase decisions and unmet industry needs.
 
 
 
 
 
108
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER
 
 
 
 
 
 
8.2.3
KEY BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
9
BIOBANKING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 87 Data Tables
 
 
 
 
 
114
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
 
 
9.2.1
EQUIPMENT
 
 
 
 
 
 
 
9.2.1.1
FREEZERS & REFRIGERATORS
 
 
 
 
 
 
 
 
9.2.1.1.1
STORAGE OF BLOOD, DNA, AND SERUM TO FUEL MARKET GROWTH
 
 
 
 
9.2.1.2
CRYOGENIC STORAGE SYSTEMS
 
 
 
 
 
 
 
 
9.2.1.2.1
RISING DEMAND FOR CELL & GENE THERAPIES TO FUEL MARKET
 
 
 
 
9.2.1.3
ALARM & MONITORING SYSTEMS
 
 
 
 
 
 
 
 
9.2.1.3.1
REGULATORY DEMAND FOR CONTINUOUS MONITORING TO SUPPORT MARKET GROWTH
 
 
 
 
9.2.1.4
THAWING EQUIPMENT
 
 
 
 
 
 
 
 
9.2.1.4.1
GROWING DEMAND FOR CAR-T AND MRNA THERAPIES TO FUEL UPTAKE
 
 
 
 
9.2.1.5
TEMPERATURE & HUMIDITY CONTROL SYSTEMS
 
 
 
 
 
 
 
 
9.2.1.5.1
CRITICAL ROLE IN MAINTAINING SAMPLE INTEGRITY TO AID ADOPTION
 
 
 
 
9.2.1.6
OTHER EQUIPMENT & ACCESSORIES
 
 
 
 
 
9.2.2
CONSUMABLES
 
 
 
 
 
 
 
9.2.2.1
SURGING SAMPLE VOLUMES AND RECURRING DEMAND TO DRIVE MARKET
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
GROWING OUTSOURCING OF SERVICES TO CROS TO DRIVE MARKET
 
 
 
 
 
9.4
SOFTWARE
 
 
 
 
 
 
 
9.4.1
GROWING FOCUS ON AUTOMATION TO PROPEL MARKET
 
 
 
 
10
BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
154
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
MANUAL EQUIPMENT
 
 
 
 
 
 
 
10.2.1
LARGE EXISTING INSTALLED BASE TO DRIVE MARKET
 
 
 
 
 
10.3
AUTOMATED EQUIPMENT
 
 
 
 
 
 
 
10.3.1
INCREASING INNOVATION AND RISING TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET
 
 
 
 
11
BIOBANKING PRODUCTS MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
162
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
SAMPLE COLLECTION & STORAGE
 
 
 
 
 
 
 
 
LARGE RESEARCH COHORTS AND SUSTAINABILITY MANDATES
 
 
 
 
 
11.3
SAMPLE PROCESSING
 
 
 
 
 
 
 
11.3.1
AUTOMATION DEMAND AND COMPLIANCE RULES TO FUEL MARKET
 
 
 
 
 
11.4
SAMPLE ANALYSIS
 
 
 
 
 
 
 
11.4.1
HIGH DEMAND FOR ACTIONABLE DATA TO FUEL MARKET
 
 
 
 
 
11.5
TRANSPORT & LOGISTICS
 
 
 
 
 
 
 
11.5.1
TEMPERATURE-SENSITIVE REQUIREMENTS TO SUPPORT PRODUCT UPTAKE
 
 
 
 
12
BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
178
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
BLOOD PRODUCTS
 
 
 
 
 
 
 
12.2.1
EASE OF COLLECTION AND ANALYTICAL VERSATILITY TO AID HIGHER ADOPTION OF BIOBANKING PRODUCTS FOR BLOOD PRODUCTS
 
 
 
 
 
12.3
SOLID TISSUES & ORGANS
 
 
 
 
 
 
 
 
REQUIREMENT OF SURGERY AND PATHOLOGIST REVIEW
 
 
 
 
 
12.4
STEM CELLS & CELL LINES
 
 
 
 
 
 
 
12.4.1
GROWING ADOPTION OF CELL & GENE THERAPIES TO AID GROWTH
 
 
 
 
 
12.5
BIOLOGICAL FLUIDS
 
 
 
 
 
 
 
12.5.1
GROWING USE OF BIOLOGICAL FLUIDS IN DISEASE-MECHANISM STUDIES TO SUPPORT MARKET GROWTH
 
 
 
 
 
12.6
NUCLEIC ACIDS
 
 
 
 
 
 
 
 
GROWING DEMAND FOR NUCLEIC ACID STORAGE AND ANALYSIS
 
 
 
 
 
12.7
HUMAN WASTE PRODUCTS
 
 
 
 
 
 
 
12.7.1
GROWING APPLICATION OF HUMAN WASTE PRODUCT SAMPLES IN MICROBIOME RESEARCH TO DRIVE MARKET
 
 
 
 
13
BIOBANKING PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
198
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
BIOBANKS
 
 
 
 
 
 
 
13.2.1
GROWING FOCUS ON LIFE SCIENCES & CLINICAL RESEARCH TO BOOST DEMAND
 
 
 
 
 
13.3
CROS
 
 
 
 
 
 
 
13.3.1
GROWING FOCUS ON BIOMARKER TRIALS AND OUTSOURCING OF SERVICES TO SUPPORT MARKET
 
 
 
 
14
BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables
 
 
 
 
 
206
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
PRIVATE/COMMERCIAL BIOBANKS
 
 
 
 
 
 
 
14.2.1
TECHNOLOGICALLY ADVANCED INFRASTRUCTURE AND COMPLIANCE OFFERINGS TO PROPEL MARKET
 
 
 
 
 
14.3
ACADEMIC & RESEARCH INSTITUTION BIOBANKS
 
 
 
 
 
 
 
14.3.1
FAVORABLE FUNDING ACTIVITIES TO BOOST DEMAND
 
 
 
 
 
14.4
NATIONAL/REGIONAL AGENCIES
 
 
 
 
 
 
 
14.4.1
GOVERNMENT FOCUS ON ADVANCING HEALTHCARE RESEARCH INITIATIVES TO DRIVE MARKET
 
 
 
 
 
14.5
HYBRID/PPP MODELS
 
 
 
 
 
 
 
14.5.1
HIGH CREDIBILITY AND AGILITY TO SUPPORT MARKET GROWTH
 
 
 
 
 
14.6
OTHER OWNERSHIP MODELS
 
 
 
 
 
15
BIOBANKING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 44 Data Tables
 
 
 
 
 
224
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
RESEARCH APPLICATIONS
 
 
 
 
 
 
 
15.2.1
LIFE SCIENCE RESEARCH
 
 
 
 
 
 
 
15.2.1.1
INCREASING FOCUS ON GENOMICS PROJECTS TO FUEL UPTAKE
 
 
 
 
 
15.2.2
CLINICAL RESEARCH
 
 
 
 
 
 
 
 
GROWING REGULATORY REQUIREMENTS AND DECENTRALIZED &
 
 
 
 
15.3
THERAPEUTIC APPLICATIONS
 
 
 
 
 
 
 
15.3.1
GROWING DEMAND FOR CELL & GENE THERAPIES TO PROPEL MARKET
 
 
 
 
 
15.4
DIAGNOSTIC APPLICATIONS
 
 
 
 
 
 
 
15.4.1
REQUIREMENT OF DISEASE-SPECIFIC SAMPLES TO BOOST DEMAND
 
 
 
 
 
15.5
OTHER APPLICATIONS
 
 
 
 
 
16
BIOBANKING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
245
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS
 
 
 
 
 
 
 
16.2.1
EXPANDING DRUG DISCOVERY & DEVELOPMENT PIPELINES TO PROPEL MARKET
 
 
 
 
 
16.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
16.3.1
ADVANCEMENTS IN RESEARCH AND FAVORABLE GRANTS TO BOOST DEMAND
 
 
 
 
 
16.4
HOSPITALS & DIAGNOSTIC LABORATORIES
 
 
 
 
 
 
 
16.4.1
USE OF SAMPLES FOR THERAPEUTIC & DIAGNOSTIC PURPOSES TO AID MARKET
 
 
 
 
17
BIOBANKING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
257
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
PHYSICAL BIOBANKING SERVICES
 
 
 
 
 
 
 
17.2.1
MEGA-COHORTS IN ONCOLOGY & POPULATION GENOMICS TO PROPEL MARKET
 
 
 
 
 
17.3
VIRTUAL BIOBANKING SERVICES
 
 
 
 
 
 
 
17.3.1
EASE OF SPECIMEN ACCESS FOR END USERS TO DRIVE MARKET
 
 
 
 
 
17.4
OTHER BIOBANKING SERVICES
 
 
 
 
 
18
BIOBANKING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 361 Data Tables.
 
 
 
 
 
268
 
18.1
INTRODUCTION
 
 
 
 
 
 
18.2
NORTH AMERICA
 
 
 
 
 
 
 
18.2.1
US
 
 
 
 
 
 
 
18.2.1.1
US TO DOMINATE NORTH AMERICAN BIOBANKING MARKET DURING FORECAST PERIOD
 
 
 
 
 
18.2.2
CANADA
 
 
 
 
 
 
 
18.2.2.1
STRONG PUBLIC INVESTMENT WITH NATIONAL RESEARCH NETWORKS AND COLLABORATIONS TO SUPPORT DISEASE-FOCUSED BIOBANKING
 
 
 
 
18.3
EUROPE
 
 
 
 
 
 
 
18.3.1
GERMANY
 
 
 
 
 
 
 
18.3.1.1
HIGH GOVERNMENT FUNDING AND FOCUS ON ADVANCED CLINICAL RESEARCH TO AUGMENT MARKET GROWTH
 
 
 
 
 
18.3.2
UK
 
 
 
 
 
 
 
18.3.2.1
PRESENCE OF LARGE-SCALE, POPULATION-BASED ADVANCED RESEARCH INFRASTRUCTURE TO PROPEL MARKET GROWTH
 
 
 
 
 
18.3.3
FRANCE
 
 
 
 
 
 
 
18.3.3.1
GROWING FOCUS ON QUALITY STANDARDS, OPEN SCIENCE, AND INTERNATIONAL COLLABORATION TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.3.4
ITALY
 
 
 
 
 
 
 
18.3.4.1
IMPROVED HEALTHCARE STANDARDS TO SUPPORT BIOBANKING STUDIES IN CANCER, RARE DISEASES, AND PERSONALIZED MEDICINE HEALTHCARE
 
 
 
 
 
18.3.5
SPAIN
 
 
 
 
 
 
 
18.3.5.1
ADOPTION OF INTERNATIONAL STANDARDS AND ADVANCED GOVERNMENT-BACKED INFRASTRUCTURE TO AID MARKET GROWTH
 
 
 
 
 
18.3.6
REST OF EUROPE
 
 
 
 
 
18.4
ASIA PACIFIC
 
 
 
 
 
 
 
18.4.1
CHINA
 
 
 
 
 
 
 
18.4.1.1
INCREASED RESEARCH COLLABORATIONS AND ADVANCEMENTS IN BIOBANK INFRASTRUCTURE TO DRIVE MARKET
 
 
 
 
 
18.4.2
JAPAN
 
 
 
 
 
 
 
18.4.2.1
STRONG GENOMIC RESEARCH OUTPUT AND FOCUS ON AI-DRIVEN POLYGENIC RISK SCORING TO BOOST PREDICTIVE HEALTHCARE INNOVATION
 
 
 
 
 
18.4.3
INDIA
 
 
 
 
 
 
 
18.4.3.1
NATIONAL AND DISEASE-SPECIFIC INITIATIVES FOR ADVANCED PRECISION MEDICINE AND HEALTHCARE INNOVATION TO AID MARKET GROWTH
 
 
 
 
 
18.4.4
SOUTH KOREA
 
 
 
 
 
 
 
18.4.4.1
INCREASED QUALITY STANDARDS AND MORE INTERNATIONAL COLLABORATIONS TO SUPPORT HUMAN AND ENVIRONMENTAL BIOBANKING
 
 
 
 
 
18.4.5
AUSTRALIA
 
 
 
 
 
 
 
18.4.5.1
INCREASING NATIONAL INVESTMENTS IN DISEASE-SPECIFIC, MICROBIOME, AND WILDLIFE BIOBANKS TO ACCELERATE MARKET GROWTH
 
 
 
 
 
18.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
18.5
LATIN AMERICA
 
 
 
 
 
 
 
18.5.1
BRAZIL
 
 
 
 
 
 
 
18.5.1.1
GENETIC DIVERSITY AND LARGE-SCALE STEM CELL & GENOMIC INITIATIVES TO PROPEL MARKET GROWTH
 
 
 
 
 
18.5.2
MEXICO
 
 
 
 
 
 
 
18.5.2.1
FAVORABLE INITIATIVES FOR IMPROVING POPULATION HEALTH RESEARCH AND REPRESENTATION IN GLOBAL GENOMIC DATABASES TO DRIVE MARKET
 
 
 
 
 
18.5.3
REST OF LATIN AMERICA
 
 
 
 
 
18.6
MIDDLE EAST
 
 
 
 
 
 
 
18.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
18.6.1.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
18.6.1.1.1
INVESTMENTS IN AUTOMATED EQUIPMENT BIOBANK INFRASTRUCTURE, ISO ACCREDITATION, AND VISION 2030 TO BOOST MARKET GROWTH
 
 
 
 
18.6.1.2
UAE
 
 
 
 
 
 
 
 
18.6.1.2.1
INVESTMENTS IN AI-DRIVEN ROBOTIC BIOBANKING TO FUEL MARKET GROWTH
 
 
 
 
18.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
 
18.6.2
REST OF MIDDLE EAST
 
 
 
 
 
18.7
AFRICA
 
 
 
 
 
 
 
18.7.1
GROWING STANDARDIZATION EFFORTS, INTERNATIONAL ACCREDITATION, AND CAPACITY-BUILDING TO PROPEL MARKET GROWTH
 
 
 
 
19
COMPETITIVE LANDSCAPE
Uncover strategic moves and market positions shaping the biobanking industry's competitive edge.
 
 
 
 
 
405
 
19.1
INTRODUCTION
 
 
 
 
 
 
19.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
19.3
REVENUE ANALYSIS OF BIOBANKING PRODUCTS MARKET, 2021–2025
 
 
 
 
 
 
 
19.4
MARKET SHARE ANALYSIS OF BIOBANKING PRODUCTS MARKET, 2025
 
 
 
 
 
 
 
19.5
REVENUE ANALYSIS OF BIOBANKING SERVICE MARKET, 2021–2025
 
 
 
 
 
 
 
19.6
MARKET SHARE ANALYSIS OF BIOBANKING SERVICE MARKET, 2025
 
 
 
 
 
 
 
19.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
19.7.1
STARS
 
 
 
 
 
 
19.7.2
EMERGING LEADERS
 
 
 
 
 
 
19.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
19.7.4
PARTICIPANTS
 
 
 
 
 
 
19.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
19.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
19.7.5.2
REGIONAL FOOTPRINT
 
 
 
 
 
 
19.7.5.3
OFFERING FOOTPRINT
 
 
 
 
 
 
19.7.5.4
SAMPLE TYPE FOOTPRINT
 
 
 
 
 
 
19.7.5.5
WORKFLOW FOOTPRINT
 
 
 
 
19.8
COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025
 
 
 
 
 
 
 
 
19.8.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
19.8.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
19.8.3
DYNAMIC COMPANIES
 
 
 
 
 
 
19.8.4
STARTING BLOCKS
 
 
 
 
 
 
19.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
19.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
19.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
19.9
COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING PRODUCTS MARKET
 
 
 
 
 
 
 
19.9.1
COMPANY VALUATION
 
 
 
 
 
 
19.9.2
FINANCIAL METRICS
 
 
 
 
 
19.10
COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING SERVICES MARKET
 
 
 
 
 
 
 
19.10.1
COMPANY VALUATION
 
 
 
 
 
 
19.10.2
FINANCIAL METRICS
 
 
 
 
 
19.11
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
19.12
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
19.12.1
PRODUCT LAUNCHES
 
 
 
 
 
 
19.12.2
DEALS
 
 
 
 
 
 
19.12.3
EXPANSIONS
 
 
 
 
20
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
432
 
20.1
KEY PLAYERS
 
 
 
 
 
 
 
20.1.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
20.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
20.1.1.2
PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
20.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
20.1.1.3.1
PRODUCT LAUNCHES
 
 
 
 
 
 
20.1.1.3.2
DEALS
 
 
 
 
 
 
20.1.1.3.3
EXPANSIONS
 
 
 
 
20.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
20.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
20.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
20.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
20.1.2
PHC HOLDINGS CORPORATION
 
 
 
 
 
 
20.1.3
BECTON, DICKINSON AND COMPANY (BD)
 
 
 
 
 
 
20.1.4
QIAGEN
 
 
 
 
 
 
20.1.5
MERCK KGAA
 
 
 
 
 
 
20.1.6
AVANTOR, INC.
 
 
 
 
 
 
20.1.7
CRYOPORT
 
 
 
 
 
 
20.1.8
TECAN TRADING AG
 
 
 
 
 
 
20.1.9
AZENTA US INC.
 
 
 
 
 
 
20.1.10
GREINER AG
 
 
 
 
 
 
20.1.11
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
20.1.12
LABCORP
 
 
 
 
 
 
20.1.13
EUROFINS SCIENTIFIC
 
 
 
 
 
 
20.1.14
EPPENDORF SE
 
 
 
 
 
 
20.1.15
SARTORIUS AG
 
 
 
 
 
 
20.1.16
DANAHER CORPORATION
 
 
 
 
 
 
20.1.17
IQVIA HOLDING INC.
 
 
 
 
 
 
20.1.18
ICON PLC
 
 
 
 
 
20.2
OTHER PLAYERS
 
 
 
 
 
 
 
20.2.1
HAIER BIOMEDICAL
 
 
 
 
 
 
20.2.2
HAMILTON COMPANY
 
 
 
 
 
 
20.2.3
AMSBIO
 
 
 
 
 
 
20.2.4
BAY BIOSCIENCES
 
 
 
 
 
 
20.2.5
BIOKRYO
 
 
 
 
 
 
20.2.6
SPT LABTECH LTD.
 
 
 
 
 
 
20.2.7
ASKION GMBH
 
 
 
 
 
 
20.2.8
CTIBIOTECH
 
 
 
 
 
 
20.2.9
CURELINE
 
 
 
 
 
 
20.2.10
SOPACHEM
 
 
 
 
 
 
20.2.11
FROILABO
 
 
 
 
 
 
20.2.12
BIOIVT
 
 
 
 
 
 
20.2.13
SAPIO SCIENCES
 
 
 
 
 
 
20.2.14
TOBIN SCIENTIFIC
 
 
 
 
21
RESEARCH METHODOLOGY
 
 
 
 
 
524
 
21.1
RESEARCH DATA
 
 
 
 
 
 
 
21.1.1
SECONDARY DATA
 
 
 
 
 
 
 
21.1.1.1
KEY SOURCES OF SECONDARY DATA
 
 
 
 
 
 
21.1.1.2
KEY OBJECTIVES OF SECONDARY RESEARCH
 
 
 
 
 
21.1.2
PRIMARY DATA
 
 
 
 
 
 
 
21.1.2.1
BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
21.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
 
 
 
 
21.2
MARKET ESTIMATION METHODOLOGY
 
 
 
 
 
 
 
21.2.1
GLOBAL MARKET SIZE ESTIMATION, 2025
 
 
 
 
 
 
 
21.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
 
 
 
 
 
 
21.2.1.2
MNM REPOSITORY ANALYSIS
 
 
 
 
 
 
21.2.1.3
PRIMARY INTERVIEWS
 
 
 
 
 
 
21.2.1.4
INSIGHTS FROM PRIMARY SOURCES
 
 
 
 
 
21.2.2
SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)
 
 
 
 
 
21.3
MARKET GROWTH RATE FORECAST
 
 
 
 
 
 
 
21.3.1
IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
 
 
 
 
 
21.4
DATA TRIANGULATION
 
 
 
 
 
 
21.5
STUDY ASSUMPTIONS
 
 
 
 
 
 
21.6
RESEARCH LIMITATIONS & RISK ASSESSMENT
 
 
 
 
 
22
APPENDIX
 
 
 
 
 
539
 
22.1
DISCUSSION GUIDE
 
 
 
 
 
 
22.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
22.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
22.4
RELATED REPORTS
 
 
 
 
 
 
22.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
BIOBANKING MARKET: IMPACT ANALYSIS
 
 
 
 
 
 
TABLE 3
BIOBANKING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 4
BIOBANKING MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE TREND OF BIOBANKING SOLUTIONS, BY PRODUCT, 2025 (USD)
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE TREND OF BIOBANKING SOLUTIONS, BY SERVICE, 2025 (USD)
 
 
 
 
 
 
TABLE 7
AVERAGE SELLING PRICE TREND OF BIOBANKING EQUIPMENT, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 8
IMPORT DATA FOR HS CODE 8418, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 9
EXPORT DATA HS CODE 9027, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
IMPORT VOLUME HS CODE 9027, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 11
EXPORT VOLUME HS CODE 9027, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 12
BIOBANKING MARKET: KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 13
CASE STUDY 1: AUTOMATING SAMPLE STORAGE TO SCALE LARGE-SCALE BIOBANKING
 
 
 
 
 
 
TABLE 14
CASE STUDY 2: DIGITIZING BIOBANK INVENTORY TO IMPROVE SAMPLE TRACEABILITY AND FUTURE USE
 
 
 
 
 
 
TABLE 15
CASE STUDY 3: AUTOMATE BIOBANK SAMPLE PROCESSING TO IMPROVE TRACEABILITY AND STORAGE EFFICIENCY
 
 
 
 
 
 
TABLE 16
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 17
INDICATIVE LIST OF PATENTS IN BIOBANKING MARKET, 2025
 
 
 
 
 
 
TABLE 18
CASE STUDIES OF AI IMPLEMENTATION IN BIOBANKING MARKET
 
 
 
 
 
 
TABLE 19
CLIENT’S READINESS TO ADOPT GENERATIVE AI IN BIOBANKING MARKET
 
 
 
 
 
 
TABLE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
 
 
 
 
 
 
TABLE 21
KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER
 
 
 
 
 
 
TABLE 22
BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER
 
 
 
 
 
 
TABLE 23
BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 24
BIOBANKING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 25
NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 26
EUROPE: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
LATIN AMERICA: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
MIDDLE EAST: BIOBANKING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
GCC COUNTRIES: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
BIOBANKING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
EUROPE: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
BIOBANKING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
EUROPE: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
NORTH AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
EUROPE: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
ASIA PACIFIC: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
LATIN AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
MIDDLE EAST: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
GCC COUNTRIES: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
NORTH AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
EUROPE: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
ASIA PACIFIC: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
LATIN AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
MIDDLE EAST: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
GCC COUNTRIES: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
NORTH AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
EUROPE: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
ASIA PACIFIC: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
LATIN AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
MIDDLE EAST: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
GCC COUNTRIES: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
NORTH AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
EUROPE: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
ASIA PACIFIC: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
LATIN AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
MIDDLE EAST: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
GCC COUNTRIES: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
NORTH AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
EUROPE: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
ASIA PACIFIC: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
LATIN AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MIDDLE EAST: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
GCC COUNTRIES: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
NORTH AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
EUROPE: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
ASIA PACIFIC: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
LATIN AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
MIDDLE EAST: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
GCC COUNTRIES: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
BIOBANKING CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
EUROPE: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
MIDDLE EAST: BIOBANKING CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
GCC COUNTRIES: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
MIDDLE EAST: BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
BIOBANKING SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
MIDDLE EAST: BIOBANKING SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
GCC COUNTRIES: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
MANUAL BIOBANKING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
NORTH AMERICA: MANUAL BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
EUROPE: MANUAL BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
ASIA PACIFIC: MANUAL BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
LATIN AMERICA: MANUAL BIOBANKING EQUIPMENT MARKET,BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
MIDDLE EAST: MANUAL BIOBANKING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
GCC COUNTRIES: MANUAL BIOBANKING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
AUTOMATED BIOBANKING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
NORTH AMERICA: AUTOMATED BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
EUROPE: AUTOMATED BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
ASIA PACIFIC: AUTOMATED BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
LATIN AMERICA: AUTOMATED BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
MIDDLE EAST: AUTOMATED BIOBANKING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
GCC COUNTRIES: AUTOMATED BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
EUROPE: BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 155
BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
EUROPE: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
EUROPE: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
EUROPE: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
EUROPE: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
EUROPE: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
EUROPE: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
EUROPE: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
EUROPE: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
EUROPE: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
EUROPE: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
NORTH AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
EUROPE: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
ASIA PACIFIC: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
LATIN AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
MIDDLE EAST: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
GCC COUNTRIES: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
BIOBANKING MARKET FOR CLINICAL RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
NORTH AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
EUROPE: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
ASIA PACIFIC: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
LATIN AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
MIDDLE EAST: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
GCC COUNTRIES: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
NORTH AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
EUROPE: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
ASIA PACIFIC: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
LATIN AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
MIDDLE EAST: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
GCC COUNTRIES: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
NORTH AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
EUROPE: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
ASIA PACIFIC: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
LATIN AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
MIDDLE EAST: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
GCC COUNTRIES: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
NORTH AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
EUROPE: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
ASIA PACIFIC: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
LATIN AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
MIDDLE EAST: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
GCC COUNTRIES: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
BIOBANKING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
EUROPE: BIOBANKING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
EUROPE: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
PHYSICAL BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
NORTH AMERICA: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
EUROPE: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
ASIA PACIFIC: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
LATIN AMERICA: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
MIDDLE EAST: PHYSICAL BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
GCC COUNTRIES: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
VIRTUAL BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
NORTH AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
EUROPE: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
ASIA PACIFIC: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
LATIN AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
MIDDLE EAST: VIRTUAL BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
GCC COUNTRIES: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
OTHER BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
NORTH AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
EUROPE: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
ASIA PACIFIC: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
LATIN AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
MIDDLE EAST: OTHER BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
GCC COUNTRIES: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
BIOBANKING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
NORTH AMERICA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
NORTH AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
NORTH AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
NORTH AMERICA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
US: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
US: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
US: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
US: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
US: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
US: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
US: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
US: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
US: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
US: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
US: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
US: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
CANADA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
CANADA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
CANADA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
CANADA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
CANADA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
CANADA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
CANADA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
CANADA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
CANADA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
CANADA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
CANADA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
EUROPE: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
EUROPE: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
EUROPE: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
EUROPE: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
EUROPE: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
GERMANY: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
GERMANY: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
GERMANY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
GERMANY: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
GERMANY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
GERMANY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
GERMANY: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
GERMANY: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
GERMANY: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
GERMANY: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
GERMANY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
UK: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
UK: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
UK: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
UK: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
UK: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
UK: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
UK: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
UK: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
UK: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
UK: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
UK: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
UK: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
FRANCE: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
FRANCE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
FRANCE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
FRANCE: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
FRANCE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
FRANCE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
FRANCE: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
FRANCE: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
FRANCE: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
FRANCE: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
FRANCE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
ITALY: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
ITALY: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
ITALY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
ITALY: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
ITALY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
ITALY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
ITALY: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
ITALY: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
ITALY: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
ITALY: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
ITALY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
SPAIN: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
SPAIN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
SPAIN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
SPAIN: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
SPAIN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
SPAIN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
SPAIN: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
SPAIN: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
SPAIN: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
SPAIN: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
SPAIN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
REST OF EUROPE: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
REST OF EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
REST OF EUROPE: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
REST OF EUROPE: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
REST OF EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
CHINA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
CHINA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
CHINA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
CHINA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
CHINA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
CHINA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
CHINA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
CHINA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
CHINA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
CHINA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
CHINA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
JAPAN: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
JAPAN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
JAPAN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
JAPAN: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
JAPAN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
JAPAN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
JAPAN: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
JAPAN: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
JAPAN: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
JAPAN: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
JAPAN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
INDIA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
INDIA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
INDIA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
INDIA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
INDIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
INDIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
INDIA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
INDIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
INDIA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
INDIA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
INDIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
SOUTH KOREA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
SOUTH KOREA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
SOUTH KOREA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
SOUTH KOREA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
SOUTH KOREA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
SOUTH KOREA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
SOUTH KOREA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
SOUTH KOREA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
AUSTRALIA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
AUSTRALIA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
AUSTRALIA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
AUSTRALIA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
AUSTRALIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
AUSTRALIA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
AUSTRALIA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
AUSTRALIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
REST OF ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 548
REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 550
REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
REST OF ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 552
REST OF ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
LATIN AMERICA: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 554
LATIN AMERICA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 555
LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 556
LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 558
LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 560
LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 562
LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 564
LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
LATIN AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 566
LATIN AMERICA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 568
LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 569
BRAZIL: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 570
BRAZIL: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 571
BRAZIL: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 572
BRAZIL: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 573
BRAZIL: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 574
BRAZIL: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 575
BRAZIL: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 576
BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 577
BRAZIL: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 578
BRAZIL: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 579
BRAZIL: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 580
BRAZIL: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 581
MEXICO: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 582
MEXICO: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 583
MEXICO: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 584
MEXICO: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 585
MEXICO: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 586
MEXICO: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 587
MEXICO: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 588
MEXICO: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 589
MEXICO: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 590
MEXICO: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 591
MEXICO: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 592
MEXICO: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 593
REST OF LATIN AMERICA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 594
REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 595
REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 596
REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 597
REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 598
REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 599
REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 600
REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 601
REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 602
REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 603
REST OF LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 604
REST OF LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 605
MIDDLE EAST: BIOBANKING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 606
MIDDLE EAST: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 607
MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 608
MIDDLE EAST: BIOBANKING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 609
MIDDLE EAST: BIOBANKING SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 610
MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 611
MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 612
MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 613
MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 614
MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 615
MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 616
MIDDLE EAST: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 617
MIDDLE EAST: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 618
MIDDLE EAST: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 619
MIDDLE EAST: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 620
MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 621
GCC COUNTRIES: BIOBANKING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 622
GCC COUNTRIES: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 623
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 624
GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 625
GCC COUNTRIES: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 626
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 627
GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 628
GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 629
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 630
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 631
GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 632
GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 633
GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 634
GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 635
GCC COUNTRIES: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 636
GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 637
SAUDI ARABIA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 638
SAUDI ARABIA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 639
SAUDI ARABIA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 640
SAUDI ARABIA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 641
SAUDI ARABIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 642
SAUDI ARABIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 643
SAUDI ARABIA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 644
SAUDI ARABIA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 645
SAUDI ARABIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 646
SAUDI ARABIA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 647
SAUDI ARABIA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 648
SAUDI ARABIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 649
UAE: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 650
UAE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 651
UAE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 652
UAE: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 653
UAE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 654
UAE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 655
UAE: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 656
UAE: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 657
UAE: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 658
UAE: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 659
UAE: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 660
UAE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 661
REST OF GCC COUNTRIES: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 662
REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 663
REST OF GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 664
REST OF GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 665
REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 666
REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 667
REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 668
REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 669
REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 670
REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 671
REST OF GCC COUNTRIES: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 672
REST OF GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 673
REST OF MIDDLE EAST: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 674
REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 675
REST OF MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 676
REST OF MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 677
REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 678
REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 679
REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 680
REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 681
REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 682
REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 683
REST OF MIDDLE EAST: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 684
REST OF MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 685
AFRICA: BIOBANKING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 686
AFRICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 687
AFRICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 688
AFRICA: BIOBANKING EQUIPMENT MARKET, BY TYPE OF OPERATION , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 689
AFRICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 690
AFRICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 691
AFRICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 692
AFRICA: BIOBANKING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 693
AFRICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 694
AFRICA: BIOBANKING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 695
AFRICA: BIOBANKING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 696
AFRICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 697
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN BIOBANKING MARKET
 
 
 
 
 
 
TABLE 698
BIOBANKING PRODUCTS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 699
BIOBANKING SERVICES MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 700
BIOBANKING MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 701
BIOBANKING MARKET: OFFERING FOOTPRINT
 
 
 
 
 
 
TABLE 702
BIOBANKING MARKET: SAMPLE TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 703
BIOBANKING MARKET: WORKFLOW FOOTPRINT
 
 
 
 
 
 
TABLE 704
BIOBANKING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 705
BIOBANKING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
 
 
 
 
 
 
TABLE 706
BIOBANKING MARKET: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 707
BIOBANKING MARKET: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 708
BIOBANKING MARKET: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 709
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 710
THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 711
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 713
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 714
PHC HOLDINGS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 715
PHC HOLDINGS CORPORATION: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 716
PHC HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 717
PHC HOLDINGS CORPORATION: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 718
BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 719
BECTON, DICKINSON AND COMPANY (BD): PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 720
BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 721
QIAGEN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 722
QIAGEN: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 723
QIAGEN: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 725
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 726
MERCK KGAA: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 727
MERCK KGAA: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 728
AVANTOR, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 729
AVANTOR, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 730
AVANTOR, INC.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 731
CRYOPORT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 732
CRYOPORT: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 733
CRYOPORT: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 734
CRYOPORT: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 735
CRYOPORT: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 736
TECAN TRADING AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 737
TECAN TRADING AG: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 738
AZENTA US INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 739
AZENTA US INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 740
AZENTA US INC.: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 741
AZENTA US INC.: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 742
AZENTA US INC.: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 743
GREINER AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 744
GREINER AG: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 745
GREINER AG: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 746
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 747
AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 748
LABCORP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 749
LABCORP: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 750
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 751
EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 752
EPPENDORF SE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 753
EPPENDORF SE: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 754
EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 755
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 756
SARTORIUS AG: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 757
SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 758
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 759
DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 760
DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 761
DANAHER CORPORATION: DEALS, JANUARY 2023–MAY 2026
 
 
 
 
 
 
TABLE 762
IQVIA HOLDINGS INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 763
IQVIA HOLDINGS INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 764
ICON PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 765
ICON PLC: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 766
ICON PLC: DEALS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 767
ICON PLC: EXPANSIONS, JANUARY 2023–AUGUST 2026
 
 
 
 
 
 
TABLE 768
HAIER BIOMEDICAL: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 769
HAMILTON COMPANY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 770
AMSBIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 771
BAY BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 772
BIOKRYO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 773
SPT LABTECH LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 774
ASKION GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 775
CTIBIOTECH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 776
CURELINE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 777
SOPACHEM: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 778
FROILABO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 779
BIOIVT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 780
SAPIO SCIENCES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 781
TOBIN SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 782
IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
TABLE 783
BIOBANKING MARKET: RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
BIOBANKING MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
BIOBANKING MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
GLOBAL BIOBANKING MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOBANKING PRODUCTS MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 6
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOBANKING SERVICES MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 7
DISRUPTIONS INFLUENCING GROWTH OF BIOBANKING MARKET
 
 
 
 
 
 
FIGURE 8
HIGH-GROWTH SEGMENTS IN BIOBANKING MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 9
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN BIOBANKING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
INCREASING INTEGRATION OF AI, DIGITAL TECHNOLOGIES, AND AUTOMATION IN BIOBANK MANAGEMENT TO DRIVE MARKET GROWTH
 
 
 
 
 
 
FIGURE 11
PRODUCTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 12
CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
PRODUCTS TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 14
BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 15
BIOBANKING MARKET: PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 16
BIOBANKING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 17
BIOBANKING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 18
BIOBANKING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 19
TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOBANKING-RELATED PATENTS, 2015–2025
 
 
 
 
 
 
FIGURE 20
IMPACT OF AI/GEN AI ON BIOBANKING MARKET
 
 
 
 
 
 
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 22
KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER
 
 
 
 
 
 
FIGURE 23
KEY BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER
 
 
 
 
 
 
FIGURE 24
NORTH AMERICA: BIOBANKING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 25
ASIA PACIFIC: BIOBANKING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 26
REVENUE ANALYSIS OF KEY PLAYERS IN BIOBANKING PRODUCTS MARKET, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 27
MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOBANKING PRODUCTS MARKET, 2025
 
 
 
 
 
 
FIGURE 28
REVENUE ANALYSIS OF KEY PLAYERS IN BIOBANKING SERVICE MARKET, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 29
MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOBANKING SERVICE MARKET, 2025
 
 
 
 
 
 
FIGURE 30
BIOBANKING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 31
BIOBANKING MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 32
BIOBANKING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 33
EV/EBITDA OF KEY PLAYERS IN BIOBANKING PRODUCTS MARKET
 
 
 
 
 
 
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS IN BIOBANKING PRODUCTS MARKET
 
 
 
 
 
 
FIGURE 35
EV/EBITDA OF KEY PLAYERS IN BIOBANKING SERVICES MARKET
 
 
 
 
 
 
FIGURE 36
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS IN BIOBANKING SERVICES MARKET
 
 
 
 
 
 
FIGURE 37
BIOBANKING PRODUCTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF BIOBANKING INSTRUMENTS
 
 
 
 
 
 
FIGURE 38
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
QIAGEN: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
MERCK KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
AVANTOR, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
CRYOPORT: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
TECAN TRADING AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 46
AZENTA US INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 47
GREINER AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 48
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 49
LABCORP: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 50
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 51
EPPENDORF SE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 52
SARTORIUS AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 53
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 54
IQVIA HOLDINGS INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 55
ICON PLC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 56
BIOBANKING MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 57
BIOBANKING MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
 
 
 
 
 
 
FIGURE 58
BIOBANKING PRODUCTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
 
 
 
 
 
 
FIGURE 59
BIOBANKING SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
 
 
 
 
 
 
FIGURE 60
BIOBANKING PRODUCTS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2025
 
 
 
 
 
 
FIGURE 61
BIOBANKING SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2025
 
 
 
 
 
 
FIGURE 62
ILLUSTRATIVE EXAMPLE OF CRYOPORT, INC.: REVENUE SHARE ANALYSIS, 2025
 
 
 
 
 
 
FIGURE 63
BIOBANKING MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 64
BIOBANKING MARKET: SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
 
 
 
 
 
 
FIGURE 65
BIOBANKING PRODUCTS MARKET: CAGR PROJECTIONS (2026–2031)
 
 
 
 
 
 
FIGURE 66
BIOBANKING SERVICES MARKET: CAGR PROJECTIONS (2026–2031)
 
 
 
 
 
 
FIGURE 67
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

 

Methodology

This study involved four major activities to estimate the current size of the biobanking market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. Following this, data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. Secondary sources for this study included publications from government sources, such as the European, Middle Eastern & African Society for Biopreservation and Biobanking (ESBB), Biobanking and BioMolecular Resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC), International Society for Biological and Environmental Repositories (ISBER), National Institutes of Health (NIH), and the US Food and Drug Administration (US FDA), as well as ScienceDirect and several others. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global Biobanking market, and the findings were validated through primary research.

Primary Research

In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess market prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

Biobanking Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the biobanking market was estimated using multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Biobanking Market : Top-Down and Bottom-Up Approach

Biobanking Market Top Down and Bottom Up Approach

Data Triangulation

After estimating the overall market size through the market size estimation process, the total market was divided into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved analyzing various factors and trends from both the demand and supply sides.

Market Definition

Biobanking involves collecting, processing, storing, and managing biological samples—such as blood, tissues, stem cells, nucleic acids, and other human-derived materials—for research, diagnostic, and therapeutic applications. The market includes equipment, consumables, software, and services used by CROs, biobanks, pharmaceutical and biotechnology companies, and academic and research institutions. These entities manage diverse sample types, including blood products, human tissues, stem cells and cell lines, nucleic acids, biological fluids, and human waste products, using manual or automated systems depending on technological adoption. The market is also segmented by ownership models, including academic and research institutions, national and regional agencies, private organizations, and other entities.

Key Stakeholders

  • Academic & Research Institutes
  • Biobanks
  • Contract Research Organizations (CROs)
  • Market Research and Consulting Firms
  • Pharmaceutical and Biotechnology Companies
  • Regulatory Agencies
  • Venture Capitalists
  • Forensics Labs
  • Government organizations
  • Private research firms
  • Hospitals and Diagnostic Laboratories

Report Objectives

  • To define, describe, and forecast the biobanking market by offering, equipment-operation type, service-ownership, product-sample type, application, product-end user, service-end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall biobanking market
  • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC Countries (Saudi Arabia (KSA), United Arab Emirates (UAE), and the Rest of GCC Countries) and the Rest of Middle East], and Africa
  • To profile the key players and analyze their market share and core competencies
  • To analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Available customizations:

With the given market data, MarketsandMarkets offers customization as per the company’s specific needs. The following options are available for the report:

Geographical Analysis

  • Further breakdown of Rest of Europe biobanking market, by country
  • Further breakdown of Rest of Asia Pacific biobanking market, by country

Comapany Information

  • Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

  • Cross-segment analysis

 

Frequently Asked Questions (FAQ)

Who are the key players in the biobanking market?

Thermo Fisher Scientific Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (BD) (US), Qiagen (Germany), Merck KGaA (Germany), Labcorp (US), Eurofins Scientific (Luxembourg), Cryoport (US)

Which product segment dominates the biobanking offerings market?

The products segment dominates the market due to its essential role in sample storage, processing, and long-term preservation, ensuring sample integrity for future research.

Which sample type segment is expected to contribute the largest share?

The blood products segment holds the largest share, owing to its versatility and status as the gold-standard for multi-omic analyses including biomarker screening, proteogenomics, and metabolomics.

Which biobanking services end-user segment accounted for the largest share of the market?

Pharmaceutical & biotechnology companies and CROs held the largest share in 2024, driven by growing R&D in regenerative medicine, investments in advanced therapies, and personalized medicine efforts.

What is the market size for the biobanking market?

The biobanking market is expected to grow at a CAGR of 9.1% from 2025 to 2030, increasing from USD 7.65 billion in 2025 to USD 11.82 billion by 2030.

Table of Contents

Methodology

 Request Customization Speak to Analyst
Speak to Analyst
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Biobanking Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Biobanking Market

DMCA.com Protection Status
popup img